- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
is a division of
- PR Newswire
- Financial Agreements
News of the day
DxTech Receives Development Funding
1st October 2008 MERRIMACK, New Hampshire, October 1 /PRNewswire/ -- DxTech LLC ("DxTech"), an innovative company focused on defining a new direction in global diagnostics by putting high-quality diagnostic information in the hands of the physicians in real time, has received development funding from PetroTech Holdings Corp., a majority owned subsidiary of the Laurus Family of Funds. DxTech is developing the fully-integrated Vantix(TM) point-of-care ("POC") diagnostics system based on proprietary P3... moreTrillium Secures Additional Financing on the Strength of Lead Program and Proprietary Position Around the CD200 Immunoregulatory Pathway
18th September 2008 TORONTO, Canada, September 18 /PRNewswire/ -- Trillium Therapeutics Inc., a privately-held biopharmaceutical company specializing in the development of innovative therapies for the treatment of immune-mediated disorders, announced today that it has secured CDN$12 million in new financing from its existing investors, VenGrowth Private Equity Partners, BDC Capital and Canadian Medical Discoveries Fund (CMDF). "We are fortunate to have the continued support of some of Canada's premier... moreEnigma Diagnostics Announces an Award of GBP 1.8 Million From UK Government
18th September 2008 PORTON DOWN, England, September 18 /PRNewswire/ -- Enigma Diagnostics, the decentralised and point-of-care molecular diagnostics Company, announces that it has been awarded a grant of GBP1.8M from the UK Government's Technology Strategy Board under the "Technologies for Health" programme. The objective of the programme is to develop a "gold-standard" portable, rapid, automated DNA analysis (PRADA) molecular test system for the diagnosis of infectious diseases in decentralised and... more PR Newswire search
Most viewed
- Moleac Announces Series A Investment
- Non-Invasive Glucose Monitoring - Solianis Monitoring AG: Supported by the Zürich Cantonal Bank and the European Union
- Dutch Top Institute Allocates 150 Million Euro to R&D Projects Targeting Early Diagnosis and Treatment of Disease
- Hikma - 2007 Preliminary Results Interviews With CEO and CFO
- Merck Serono and Bionomics Announce Multiple Sclerosis Development and Licensing Agreement
More recent news
BioCis Pharma Receives 1.6 Million EURO New Financing to Speed the Clinical Phase I/II Programme of the Company's Dermatology Product
9th September 2008 TURKU, Finland, September 9 /PRNewswire/ -- BioCis Pharma Ltd announced that it has received almost 1.6
million EURO new R&D financing. The money is specifically targeted for the
clinical testing of...
Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
21st August 2008 NEW DELHI, August 21 /PRNewswire/ -- Omaxe Infrastructure & Construction Private Ltd(OICPL), a
wholly owned subsidiary of Omaxe Ltd has received a Letter of Intent for the
construction of Allopathic...
MDL Receives GBP600k in New Funding Round for World-Beating Cancer Diagnosis and Treatment Device
4th August 2008 LONDON, August 4 /PRNewswire/ -- Successful results and growing sales of Michelson Diagnostics Ltd's (MDL)
Optical Coherence Technology (OCT) systems have encouraged investors to place
a further...
French Agency Receives 10 Million Dollar Grant From the Bill & Melinda Gates Foundation to Support the Establishment of National Vaccine Advisory Committees in Africa and Asia
31st July 2008 PARIS, July 31 /PRNewswire/ -- The French agency Agence de Médecine Préventive (AMP) has
received a grant of 10 million dollars from the Bill & Melinda Gates
Foundation to support the development...
Patheon Reaches Agreement With BSP Pharmaceuticals for Development and Manufacture of Cytotoxics
2nd July 2008 TORONTO, July 2 /PRNewswire/ -- Patheon (TSX:PTI), a global provider of drug development and
manufacturing services to the international pharmaceutical industry, has
completed a shareholders...
Elsevier Foundation Seeks Grant Proposals for Innovative Libraries and New Scholars
24th June 2008 NEW YORK, June 24 /PRNewswire/ -- The Elsevier Foundation is seeking grant proposals for its Innovative
Libraries in Developing Countries and New Scholars programs. Grant proposals
for the two...
Merck Serono and Bionomics Announce Multiple Sclerosis Development and Licensing Agreement
18th June 2008 GENEVA, June 18 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany,
announced today that a Development and Licensing Agreement with Bionomics
(ASX: BNO) was signed, under...
Angioslide Closes US$8.6million Series C Financing
2nd June 2008 HERZLIYA, Israel, June 2 /PRNewswire/ -- Angioslide, Ltd. today announced the closing of an US$8.6 million Series
C financing round. Angioslide is the developer of the unique Angioslide
eXtra(TM)...
Strong VC-trio Invest in PharmaSurgics Wound Healing Product
28th May 2008 GOTHENBURG, Sweden, May 28 /PRNewswire/ -- PharmaSurgics AB has received SEK 17 million to complete the preclinical
development of their candidate drug (PXL01). The primary indication for PXL01
is...
Emerging Capital Partners Invests U.S. $47.3 Million in North African Personal Care Company
21st May 2008 WASHINGTON, May 21 /PRNewswire/ -- Emerging Capital Partners (ECP), an international private equity firm
focused on investing across the African continent, today announced a U.S.
$47.3 million...
Albireo Announces Second Closing of Series A Financing
7th May 2008 GOTHENBURG, Sweden, May 7 /PRNewswire/ -- Albireo, a recent spinout from AstraZeneca focused on gastrointestinal
diseases, today announced a second closing of its Series A financing.
The capital...
Non-Invasive Glucose Monitoring - Solianis Monitoring AG: Supported by the Zürich Cantonal Bank and the European Union
5th May 2008 ZURICH, Switzerland, May 5 /PRNewswire/ -- The research for non-invasive glucose monitoring has found new
investors: The Zürich Cantonal Bank will invest in Solianis; together with a
research grant...
Submissions for the 2008 EFIC-Grunenthal Grant
21st April 2008 AACHEN, Germany, April 21 /PRNewswire/ -- Submissions for the 2008 EFIC-Grunenthal Grant will be accepted by 31st
May 2008. This annual grant of EUR 100,000 is awarded in co-operation with
the...
Potentia Pharmaceuticals Secures Additional US$12 Million in Funding
9th April 2008 LOUISVILLE, Kentucky, April 9 /PRNewswire/ -- Potentia Pharmaceuticals, Inc., a private development-stage biotechnology
company, announced today that it has completed a US$12 million round...
D-Pharm Secures Funding From Israel's Chief Scientist's Office
7th April 2008 REHOVOT, Israel, April 7 /PRNewswire/ -- D-Pharm announced today that it received notice from Israel's Chief
Scientist's Office (CSO) of its commitment to match expenditures on four of
D-Pharm's...
Moleac Announces Series A Investment
3rd April 2008 SINGAPORE, April 3 /PRNewswire/ -- Singapore-based Moleac announced that it has raised US$3.5 million. This
Series A investment comes from a group of private investors, who are based in
both Europe...
Dutch Top Institute Allocates 150 Million Euro to R&D Projects Targeting Early Diagnosis and Treatment of Disease
1st April 2008 EINDHOVEN, the Netherlands, April 1 /PRNewswire/ -- The Center for Translational Molecular Medicine (CTMM) - a Dutch
public-private partnership committed to the research and development of...
Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round
27th March 2008 FREISING-WEIHENSTEPHAN, Germany, March 27 /PRNewswire/ -- Pieris AG, a bio-pharmaceutical company developing Anticalins(R), a novel
class of targeted human protein therapeutics, announced today the...
Hikma - 2007 Preliminary Results Interviews With CEO and CFO
18th March 2008 LONDON, March 18 /PRNewswire/ -- In video interviews Said Darwazah, CEO, and Bassam Kanaan, CFO, discuss
Hikma's 2007 performance, financing and acquisitions, plus what they are
expecting from the...
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us